
Prexol 0.75mg Tablet SR
Marketer
Alteus Biogenics Pvt Ltd
Salt Composition
Pramipexole (0.75mg)
Overview Prexol 0.75mg Tablet SR
Parkinson's disease and restless legs syndrome (characterized by an irresistible urge to move legs due to unpleasant sensations) are treated with Prexol 0.75mg sustained-release tablets. This medication reduces excessive tremors by moderating body movements. Administer Prexol 0.75mg SR with food, consistently at the same time daily for optimal therapeutic levels. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even with symptom improvement; never discontinue doses prematurely. Abrupt cessation requires prior consultation with your doctor. Common adverse effects include nausea, dry mouth, tiredness, visual disturbances (hallucinations), constipation, and swelling in the extremities (peripheral edema). Drowsiness and dizziness are also possible; avoid driving or mentally demanding activities until the drug's effects are known. Report any unusual mood shifts, heightened libido, compulsive gambling, or excessive spending to your doctor immediately, as these can be serious.
Primary Ingredients of Prexol 0.75mg Tablet SR
No text provided to rephrase.
Uses of Prexol 0.75mg Tablet SR
Parkinson's disease|Restless leg syndrome
Major Benefits of Prexol 0.75mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It is recommended to take Prexol 0.75mg Tablet SR with a meal.
Common Side effects of Prexol 0.75mg Tablet SR:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Prexol 0.75mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Prexol 0.75mg Tablet SR should be administered with a meal.
How Prexol 0.75mg Tablet SR works:
Prexol 0.75mg Tablet SR works by mimicking the action of dopamine, a chemical messenger that is needed to control movement in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Prexol 0.75mg extended-release tablets and alcohol can lead to heightened somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Prexol 0.75mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Prexol 0.75mg Tablet SR is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant. Prexol 0.75mg Tablet SR's prolactin-suppressing action could negatively impact lactation.
DrivingUNSAFE
Driving ability may be impaired by side effects of Prexol 0.75mg Tablet SR, including hallucinations – sensations of sights, sounds, or feelings that are not real.
KidneyCAUTION
Patients with kidney impairment should use Prexol 0.75mg Tablet SR cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The extended-release Prexol 0.75mg tablet is likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Prexol 0.75mg Tablet SR :
If you miss a dose of Prexol 0.75mg Tablet SR, skip it and continue with your normal schedule. Do not double the dose.
Facts to Know About Prexol 0.75mg Tablet SR
| Label | Value |
|---|---|
| Type of Compound | Benzothiazole-based compound |
| Potential for Dependence | None. |
| Type of Medication | Central and peripheral nervous system |
| Mechanism of Action | Drugs that stimulate dopamine receptors |
